From Casetext: Smarter Legal Research

Cytosport, Inc. v. Vital Pharmaceuticals

United States Court of Appeals, Ninth Circuit
Oct 13, 2009
348 F. App'x 288 (9th Cir. 2009)

Summary

finding likely irreparable harm if defendant was allowed to continue “flood[ing] the marketplace” with an infringing product

Summary of this case from Adidas Am., Inc. v. Skechers U.S., Inc.

Opinion

No. 09-15969.

Submitted September 14, 2009.

Filed October 13, 2009.

Jed H. Hansen, Peter M. De Jonge, Thorpe North Western LLP, Sandy, UT, Glenn W. Peterson, Millstone Peterson Watts, LLP, Roseville, CA, Mark M. Betilyon, Samuel C. Straight, Ray Quinney Nebeker, P.C., Salt Lake City, UT, for Plaintiff-Appellee.

Ramsey M. Al-Salam, Partner, Perkins Coie LLP, Seattle, WA, Gigi Chau Hoang, Jason A. Yurasek, Perkins Coie LLP, San Francisco, CA, Erica W. Stump, Esquire, General Counsel, Vital Pharmaceuticals, Inc., Davie, FL, for Defendant-Appellant.

Appeal from the United States District Court for the Eastern District of California, Frank C. Damrell, District Judge, Presiding. D.C. No. 2:08-cv-02632-FCD-GGH.

Before: SILVERMAN, RAWLINSON, and CLIFTON, Circuit Judges.


MEMORANDUM

This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.


This appeal from the district court's order granting appellee's motion for a preliminary injunction comes to us for review under Ninth Circuit Rule 3-3. We have jurisdiction under 28 U.S.C. § 1292(a)(1), and we affirm.

Our sole inquiry is whether the district court abused its discretion in granting preliminary injunctive relief. See Winter v. Natural Res. Def. Council, Inc., ___ U.S.___, ___, 129 S.Ct. 365, 374, 172 L.Ed.2d 249 (2008); Marlyn Nutraceuticals, Inc., v. Mucos Pharma, 571 F.3d 873, 876 (9th Cir. 2009). Here, the district court correctly identified the legal standards for likelihood of confusion of a trademark and of trade dress. See Clicks Billiards, Inc. v. Sixshooters, Inc., 251 F.3d 1252, 1258 (9th Cir. 2001); AMF Inc. v. Sleekcraft Boats, 599 F.2d 341, 348-49 (9th Cir. 1979).

We conclude that the district court did not rely on an erroneous legal premise or abuse its discretion in concluding that Cytosport was likely to succeed on the merits and showed a strong likelihood that it would suffer irreparable harm if the preliminary injunction did not issue. Accordingly, we affirm the district court's order granting the preliminary injunction. AFFIRMED.

The 6/11/09 pro se motion to file an amicus brief is denied.


Summaries of

Cytosport, Inc. v. Vital Pharmaceuticals

United States Court of Appeals, Ninth Circuit
Oct 13, 2009
348 F. App'x 288 (9th Cir. 2009)

finding likely irreparable harm if defendant was allowed to continue “flood[ing] the marketplace” with an infringing product

Summary of this case from Adidas Am., Inc. v. Skechers U.S., Inc.
Case details for

Cytosport, Inc. v. Vital Pharmaceuticals

Case Details

Full title:CYTOSPORT, INC., a California corporation, Plaintiff-Appellee, v. VITAL…

Court:United States Court of Appeals, Ninth Circuit

Date published: Oct 13, 2009

Citations

348 F. App'x 288 (9th Cir. 2009)

Citing Cases

Zest Anchors, LLC v. Geryon Ventures, LLC

("Prima facie evidence of the development of secondary meaning is established where a mark has been…

Young v. 3.1 Phillip Lim, LLC

In the trademark context, the public interest in the injunction has been defined as "the right of the public…